E-LIB Suche - Ergebnisse für: Morales-Ramirez, Javier

1

Safety, efficacy, and dose response of the maturation inhib..:

Morales-Ramirez, Javier ; Bogner, Johannes R. ; Molina, Jean-Michel...
PLOS ONE. 13 (2018) 10 - p. e0205368 , 2018

2

Switching from a Tenofovir Disoproxil Fumarate (TDF) to a T..:

Thompson, Melanie ; Morales-Ramirez, Javier ; Mcdonald, Cheryl...
Open Forum Infectious Diseases. 2 (2015) suppl_1 - p. , 2015

Link: https://doi.org/10.1093/..

3

A phase I randomized, double-blind, placebo-controlled stud..:

Russell, Kevin L. ; Rupp, Richard E. ; Morales-Ramirez, Javier O....
Human Vaccines & Immunotherapeutics. 18 (2022) 5 - p. , 2022

Link: https://doi.org/10.1080/..

4

636. A Phase I Study to Evaluate the Safety, Tolerability, ..:

Russell, Kevin ; Rupp, Richard E ; Morales-Ramirez, Javier O...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S420-S421 , 2021

Link: https://doi.org/10.1093/..

5

Doravirine dose Selection and 96-Week Safety and Efficacy v..:

Gatell, Jose M ; Morales-Ramirez, Javier O ; Hagins, Debbie P...
Antiviral Therapy. 24 (2018) 6 - p. 425-435 , 2018

Link: https://doi.org/10.3851/..

6

Estimation of Survival in Patients with Glioblastoma Using ..:

Aguirre-Madrigal, María S ; Flores-Vázquez, José G ; Romero-Luna, Gerardo...
Cureus. , 2022

Link: https://doi.org/10.7759/..

7

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://amu.hal.science/..

8

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://amu.hal.science/..

9

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://amu.hal.science/..

10

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://amu.hal.science/..

11

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://hal-amu.archives..

12

Week 96 efficacy and safety results of the phase 3, randomi..:

Eron, Joseph ; Orkin, Chloe ; Cunningham, Douglas...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.antiviral.2019.104543. , 2019

Link: https://amu.hal.science/..

13

A phase I randomized, double-blind, placebo-controlled stud..:

Russell, Kevin L ; Rupp, Richard E ; Morales-Ramirez, Javier O...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9225326/. , 2022

Link: http://www.ncbi.nlm.nih...

14

Chronic Resistance Training Effects on Serum Adipokines in ..:

Jiménez-Martínez, Pablo ; Ramirez-Campillo, Rodrigo ; Alix-Fages, Carlos...
Healthcare. 11 (2023) 4 - p. 594 , 2023

Link: https://doi.org/10.3390/..

15

Effects of Microfiltered Seawater Intake and Variable Resis..:

Juesas, Alvaro ; Gargallo, Pedro ; Gene-Morales, Javier...
International Journal of Environmental Research and Public Health. 20 (2023) 6 - p. 4700 , 2023

Link: https://doi.org/10.3390/..